Interventional Radiotherapy (Brachytherapy) Combined with Systemic Treatment-The Influence of RAS Gene Mutations and Combined Therapy on the Results and Toxicity of Colorectal Cancer Liver Metastases. [PDF]
Cisek P +2 more
europepmc +1 more source
Estimating the Survival Impact of Curative-Intent Liver Therapies for Colorectal Cancer Liver Metastases. [PDF]
Tsagkalidis V +16 more
europepmc +1 more source
Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases. [PDF]
Crnovrsanin N +32 more
europepmc +1 more source
Comment on "Differential prognostic impact of liver resection by the site of concurrent extrahepatic diseases in patients with colorectal cancer liver metastases". [PDF]
Yang XC, Sun YH, He XH.
europepmc +1 more source
A Randomized Controlled Trial of Resection Versus Thermal Ablation of Colorectal Cancer Liver Metastases (New Comet): Study Protocol. [PDF]
Hansen IS +14 more
europepmc +1 more source
Related searches:
Transplant for colorectal cancer liver metastases
Surgery, 2023Colorectal cancer with unresectable liver metastases has significant mortality when treated with chemotherapy alone. In appropriately selected patients, liver transplant is emerging as a treatment alternative for this population. Some key clinical trials, including SECA-I and SECA-II, have shown promising survival results: more trials are being ...
Jenna N. Whitrock +2 more
openaire +2 more sources
Liver Metastases in Colorectal Cancer
American Society of Clinical Oncology Educational Book, 2016Resection of colorectal liver metastases is a treatment standard because patients experience long-term disease-free survival or are even cured after undergoing this procedure. Improved surgical techniques for liver resection in combination with downsizing liver metastases by chemotherapy, interventions to induce liver hypertrophy before resection, and
openaire +2 more sources
Surgical Management of Colorectal Cancer Liver Metastases
Hematology/Oncology Clinics of North America, 2021Approximately 50% of colorectal cancer patients develop liver metastases. Hepatic metastases represent the most common cause of colorectal cancer-related mortality. Metastasectomy, if possible, represents the most effective treatment strategy; 20% of patients will be cured and more than 50% survive at least 5 years.
Chandrasekhar, Padmanabhan +2 more
openaire +3 more sources

